<DOC>
	<DOCNO>NCT01083121</DOCNO>
	<brief_summary>Patients take Humira prescribe physician per Korean label enrol observed normal medical practice set less 3 month follow first dose Humira . Information demographic , diagnosis medical history , result tuberculosis skin test , result chest X-ray , Humira treatment information , concomitant medication , physician 's global assessment effectiveness , disease activity assessment rheumatoid arthritis , disease activity assessment Crohn 's Disease , disease activity assessment Psoriasis adverse event record case report form .</brief_summary>
	<brief_title>Surveillance Humira Injection Korean Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Adult patient ( 19 year ) one follow indication : Moderately severely active rheumatoid arthritis active progressive psoriatic arthritis response previous diseasemodifying antirheumatic drug therapy inadequate severe active ankylose spondylitis inadequate response conventional therapy severely active Crohn 's disease response , intolerance contraindication corticosteroid therapy immunosuppressant moderately severely active psoriasis patient response , intolerance contraindication systemic therapy include cyclosporine , methotrexate photochemotherapy ( PUVA ) . Patients give verbal write authorization use personal health data . Patients know hypersensitivity adalimumab excipients .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Postmarketing Drug Surveillance</keyword>
</DOC>